# K070934: Panosol II Tru-Blu, Model Ubl-417

- Pathway: 510(k) (Traditional)
- Applicant: National Biological Corp.
- Decided: May 22, 2007 after 49 days
- Product code: FTC (Light, Ultraviolet, Dermatological)
- Device class: 2
- Regulation: 21 CFR 878.4630
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
7 later devices descend from it; 1 cites it directly.
0 of 8 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Most influential descendants
- K100378: 1 Series Model 1 Series T2, 1 Series X2, 1 Series T4, 1 Series X4 (2010), 6 descendants of its own
- K182215: ClearLink Controlled Phototherapy Equipment (2018), 4 descendants of its own
- K210881: M Series Phototherapy Equipment (2021), 2 descendants of its own
- K230382: 3 Series NeoLux (2023), 1 descendant of its own
- K261775: Uv Phototherapy (KN-4001A,KN-4001B,KN-4001AB) (2026), 0 descendants of its own

## Indications for use
The Panosol II Tru-Blu UBL-417 is generally indicated to treat dermatological indications. The Panosol II Tru-Blu UBL-417 is specifically indicated to treat moderate inflammatory Acne Vulgaris

Source page: https://510kreport.com/device/K070934
Methodology: https://510kreport.com/methodology